Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Kiesewetter

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Topics in Medicinal Chemistry|July 22, 2010
PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxelKaren A Kurdziel, D O Kiesewetter
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Radiochemical synthesis of [18F]fluororacloprideD O Kiesewetter, T Brücke, R D Finn
Journal of Medicinal Chemistry|May 12, 1995
Syntheses and biological properties of chiral fluoroalkyl quinuclidinyl benzilatesD O Kiesewetter, J V Silverton, W C Eckelman
Nuclear Medicine and Biology|January 1, 1995
Synthesis of polymer-bound 6-thiolatomercury and 6-mercuric sulfonate DOPA precursors and their halodemercuration reactivityK Kawai, M A Channing, D O Kiesewetter, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1990
Synthesis of 11C-labeled (+-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imin e [(+-)-[11C]MK801]D O Kiesewetter, R D Finn, K C Rice, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 8, 2005
Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?L Ravasi, D O Kiesewetter, K Shimoji, et al.
Synapse (New York, N.Y.)|February 20, 1999
In vivo muscarinic binding of 3-(alkylthio)-3-thiadiazolyl tetrahydropyridinesD O Kiesewetter, R E Carson, E M Jagoda, et al.
Nuclear Medicine and Biology|August 1, 1995
Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brainJ Lee, C H Paik, D O Kiesewetter, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligandsD O Kiesewetter, R Kawai, M Chelliah, et al.
Life Sciences|March 9, 1999
Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligandsD O Kiesewetter, R E Carson, E M Jagoda, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Topics in Medicinal Chemistry|July 22, 2010
PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxelKaren A Kurdziel, D O Kiesewetter
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Radiochemical synthesis of [18F]fluororacloprideD O Kiesewetter, T Brücke, R D Finn
Journal of Medicinal Chemistry|May 12, 1995
Syntheses and biological properties of chiral fluoroalkyl quinuclidinyl benzilatesD O Kiesewetter, J V Silverton, W C Eckelman
Nuclear Medicine and Biology|January 1, 1995
Synthesis of polymer-bound 6-thiolatomercury and 6-mercuric sulfonate DOPA precursors and their halodemercuration reactivityK Kawai, M A Channing, D O Kiesewetter, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1990
Synthesis of 11C-labeled (+-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imin e [(+-)-[11C]MK801]D O Kiesewetter, R D Finn, K C Rice, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 8, 2005
Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?L Ravasi, D O Kiesewetter, K Shimoji, et al.
Synapse (New York, N.Y.)|February 20, 1999
In vivo muscarinic binding of 3-(alkylthio)-3-thiadiazolyl tetrahydropyridinesD O Kiesewetter, R E Carson, E M Jagoda, et al.
Nuclear Medicine and Biology|August 1, 1995
Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brainJ Lee, C H Paik, D O Kiesewetter, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligandsD O Kiesewetter, R Kawai, M Chelliah, et al.
Life Sciences|March 9, 1999
Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligandsD O Kiesewetter, R E Carson, E M Jagoda, et al.
Pageof 3